PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
批准号:
7173341
负责人:
MICHAEL S GOLIGORSKY
金额:
$29.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2011-01-31
关键词:
3-nitrotyrosineAdvanced Glycosylation End ProductsAging-Related ProcessAnimalsAntioxidantsApoptosisApoptoticAtherosclerosisBiochemicalCDKN2A geneCardiovascular systemCell AgingCell CountCell CycleCell SizeCellsCessation of lifeCollagenDecelerationDevelopmentDiabetes MellitusDisruptionEndothelial CellsEnrollmentEpidemicEventExtracellular Matrix ProteinsExtravasationFatty acid glycerol estersFructoseFunctional disorderGalactosidaseGangliosidesGeneral PopulationHumanImage AnalysisIn VitroIncidenceInsulin ResistanceInvestigationKidneyKidney DiseasesLeadLifeLightMediatingMetabolicMetabolic syndromeMicrocirculationMitochondriaMitochondrial ProteinsModelingMolecularMolecular TargetMorphologyMusNorth AmericaObesityOxidative StressOxygen ConsumptionPathway interactionsPatientsPermeabilityPeroxonitritePersonal SatisfactionPhase II Clinical TrialsPhenotypePopulationPremature aging syndromePreventionProductionProtein Kinase CProteinsRattusRoleSuperoxidesSyndromeTP53 geneTechniquesTreatment EfficacyTumor Necrosis Factor-alphaUmbilical veinVideo Microscopyactivation productantioxidant therapybaseconceptdaydesigndiabeticdiabetic ratebselenfeedinghuman TNF proteinin vivointravital fluorescence microscopymitochondrial dysfunctionnon-diabeticoxidized low density lipoproteinpreventreceptor for advanced glycation endproductsresearch studysenescence
中文摘要
描述(由申请人提供):糖尿病和代谢综合征患者心血管系统加速的动脉粥样硬化和过早老化已经达到流行的程度。我们之前对内皮细胞在模拟糖尿病环境的微环境中的研究表明,细胞衰老的发展加速。根据观察到硝基酪氨酸修饰的蛋白在过早衰老的细胞中表达增强,以及过氧亚硝酸盐处理完整细胞导致提前衰老,我们用真正的过氧亚硝酸盐清除剂/抗氧化剂ebselen处理内皮细胞。这种治疗与预防和逆转早衰有关。这些发现促使我们研究代谢综合征-Zucker糖尿病大鼠模型细胞过早衰老的分子机制(S),依布硒对内皮细胞过早衰老的影响,并观察这些动物血管病变的发展。我们假设氧化应激/过氧亚硝酸盐诱导的溶酶体功能障碍启动内皮细胞衰老和神经节苷脂的积累,这是从衰老到凋亡的分子开关--这些事件支撑着血管病变的进展。体外和体内研究采用图像分析和荧光活体显微镜,生化技术检测溶酶体和线粒体蛋白的泄漏以及神经节苷脂的积累,以及细胞周期标志物的定量分析,以探讨过早衰老和细胞凋亡的分子和细胞机制。用依布塞伦治疗Zucker糖尿病肥胖大鼠的体内研究将考察预防和逆转这种综合征的大血管和微血管病变(肾病)的可能性。这些研究可能有助于阐明内皮细胞早衰的机制,过氧亚硝酸盐在其中的作用,以及过氧亚硝酸盐清除在改善血管病变中的潜在治疗作用。
英文摘要
DESCRIPTION (provided by applicant): Accelerated atherosclerosis and premature aging of the cardiovascular system in patients with diabetes mellitus and metabolic syndrome have acquired epidemic proportions. Our previous studies of endothelial cells subjected to a microenvironment emulating the diabetic milieu revealed accelerated development of cell senescence. Based on the observations that the expression of nitrotyrosine-modified proteins was enhanced in the prematurely senescent cells and peroxynitrite treatment of intact cells led to premature senescence, we treated endothelial cells with a bona fide peroxynitrite scavenger/antioxidant ebselen. Such a treatment was associated with the prevention and reversal of premature senescence. These findings prompted us to investigate the molecular mechanism(s) of premature cell senescence, effects of ebselen on premature endothelial cell senescence in a model of metabolic syndrome - Zucker diabetic rats, and examine the development of vasculopathy in these animals. We hypothesize that oxidative stress/peroxynitrite-induced lysosomal dysfunction initiates endothelial cell senescence and accumulation of gangliosides, a molecular switch from senescence to apoptosis - events underpinning the progression of vasculopathy. In vitro and in vivo studies employing image analysis and fluorescence intravital microscopy, biochemical techniques to detect leakage of lysosomal and mitochondrial proteins as well as accumulation of gangliosides, and quantitative analysis of the markers of cell cycle are designed to investigate molecular and cellular mechanisms of premature senescence and apoptosis. In vivo studies of the Zucker diabetic fat rat treated with ebselen will be conducted to examine the possibility of preventing and reversing macro- and micro-vasculopathy (nephropathy) in this syndrome. The investigations may shed light on mechanisms of premature senescence of endothelial cells, role of peroxynitrite in initiating it, and potential therapeutic efficacy of peroxynitrite scavenging in amelioration of vasculopathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glycocalyx repair in sepsis using liposomal carriers of preassembled glycocalyx
-
批准号:10428550
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2019
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Glycocalyx repair in sepsis using liposomal carriers of preassembled glycocalyx
-
批准号:10218261
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2019
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
ENDOTHELIAL DYSFUNCTION, NITRIC OXIDE AND RENAL FAILURE
-
批准号:7990202
-
项目类别:
-
资助金额:$9.67万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:7921552
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7990210
-
项目类别:
-
资助金额:$10.1万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:8298636
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:8496014
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:7700338
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:8079698
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6342524
-
项目类别:
-
资助金额:$21.35万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7341755
-
项目类别:
-
资助金额:$28.76万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7765494
-
项目类别:
-
资助金额:$28.47万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Prevent Vasculopathy and Nephropathy in Metabolic Syndro
-
批准号:7040269
-
项目类别:
-
资助金额:$31.37万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:2716760
-
项目类别:
-
资助金额:$22.61万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6626968
-
项目类别:
-
资助金额:$21.92万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6688324
-
项目类别:
-
资助金额:$29.78万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7568804
-
项目类别:
-
资助金额:$28.76万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6489713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6138083
-
项目类别:
-
资助金额:$20.79万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
NITRIC OXIDE IN DEFENSE OF PERITONEAL CAVITY AGAINST MICROBIAL PATHOGENS--CAPD
-
批准号:6283027
-
项目类别:
-
资助金额:$2.44万
-
财政年份:1998
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
海外基金